Intelligence Platform

Patents

Browse 373 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7569580

Heterotricyclic compounds for use as HCV inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566732

Rhodanine compositions for use as antiviral agents

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563585

Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563892

Prodrugs of 2,4 pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560466

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557210

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557207

Spiro 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7550460

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7538108

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521192

EDG: modulators of lymphocyte activation and migration

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517886

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7514434

Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7511137

Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarbo

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7498435

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7498353

Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7491732

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488805

Apoptosis proteins

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7485724

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7482351

4-pyrimidineamine compounds and their uses as anti-proliferative agents

Rigel Pharmaceuticals, Inc. · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452879

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7449458

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7435814

2,4-Pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7432047

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7423118

IAPS associated cell cycle proteins, compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted